JRS Group acquires DuPont’s Alginate Business

JRS Alginate Business

JRS Group acquires DuPont’s Nutrition & Health Alginate Business

 
 

Rosenberg, Germany, May 2018 

 
 

On May 22nd, JRS Group, a leading manufacturer of functional additives from plant-based raw materials was approved by the European Commission (EC) as a suitable purchaser of the legacy DuPont N&H alginates business. The acquisition is expected to close in Q32018. 

The transaction with JRS Group includes the heritage DuPont N&H Alginate business, comprising pure and buffered alginates, and a specific portfolio of pectin-alginate blends, the associated Landerneau production site, and customer relationships. The divestiture was a requirement set out by the EC upon its conditional approval of DuPont’s acquisition of FMC’s Health & Nutrition (H&N) business in 2017.  

“The receipt of regulatory approval from the EU Commission to acquire DuPont’s Alginate business is another milestone in strengthening the Life Science Division of JRS Group. We are continuously complementing our broad product portfolio to develop innovative solutions for our global customers. JRS focusses on ‘Green Products’ made of renewable, botanical resources. Therefore, alginates perfectly fit our product portfolio of excipients and hydrocolloids for pharma, food and personal care applications. We are fully committed to ensure a seamless transition of the business and will be in contact with all customers prior to closing,” said Josef Otto Rettenmaier, President of JRS Group. 



About JRS Group 

JRS Group is a family-owned company with global activities in the area of functional additives for food, pet food, pharma, personal care and various technical application fields. JRS Group manufactures and markets products made from vegetable-based raw materials with more than 3.000 employees worldwide. By operating more than 20 fully owned international sales companies, 7 R&D centers and more than 50 production plants, JRS Group is a customer-oriented solution provider with a presence in all major countries around the globe.
More information is available at www.jrs.de and www.jrspharma.com.


All rights reserved ©2018 J.RETTENMAIER & SÖHNE GmbH + Co KG

facebook
linkedin
 

All rights reserved    © 2018 J. RETTENMAIER & SÖHNE GmbH + Co KG

Terms and Conditions    //   Privacy Policy    //   Legal Notice

facebook          LinkedIn